Picture of Acurx Pharmaceuticals logo

ACXP Acurx Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareMicro CapSucker Stock

Acurx Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

* Acurx Pharmaceuticals Inc  ACXP.OQ  reported a quarterly
adjusted loss of 17 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -24 cents.  The mean expectation of
two analysts for the quarter was for a loss of 20 cents per
share. Wall Street expected results to range from -23 cents
to -17 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acurx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 17 cents​.
    * The company reported a quarterly loss of $2.82 million.
    * Acurx Pharmaceuticals Inc shares had fallen by 2.6% this
quarter and lost 51.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is 11.89 
This summary was machine generated from LSEG data November 13 at
03:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.20          -0.17          Beat
 Jun. 30 2024      -0.22          -0.26          Missed
 Mar. 31 2024      -0.24          -0.28          Missed
 Dec. 31 2023      -0.26          -0.37          Missed

Recent news on Acurx Pharmaceuticals

See all news